Lindbrook Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$696K Buy
6,897
+1,186
+21% +$120K 0.06% 173
2024
Q4
$510K Buy
5,711
+94
+2% +$8.4K 0.05% 215
2024
Q3
$471K Sell
5,617
-32
-0.6% -$2.68K 0.04% 225
2024
Q2
$435K Sell
5,649
-144
-2% -$11.1K 0.04% 227
2024
Q1
$397K Buy
5,793
+182
+3% +$12.5K 0.04% 242
2023
Q4
$324K Buy
5,611
+1,924
+52% +$111K 0.03% 260
2023
Q3
$195K Buy
3,687
+211
+6% +$11.1K 0.02% 321
2023
Q2
$188K Buy
3,476
+1
+0% +$54 0.02% 337
2023
Q1
$174K Buy
3,475
+1,442
+71% +$72.1K 0.02% 345
2022
Q4
$94.1K Sell
2,033
-9,966
-83% -$461K 0.01% 505
2022
Q3
$465K Buy
11,999
+321
+3% +$12.4K 0.08% 151
2022
Q2
$435K Buy
11,678
+119
+1% +$4.43K 0.07% 168
2022
Q1
$512K Sell
11,559
-180
-2% -$7.97K 0.08% 158
2021
Q4
$499K Buy
11,739
+80
+0.7% +$3.4K 0.08% 166
2021
Q3
$506K Buy
11,659
+8
+0.1% +$347 0.13% 67
2021
Q2
$498K Buy
11,651
+35
+0.3% +$1.5K 0.11% 79
2021
Q1
$449K Buy
11,616
+263
+2% +$10.2K 0.1% 79
2020
Q4
$408K Buy
11,353
+16
+0.1% +$575 0.1% 84
2020
Q3
$433K Buy
11,337
+42
+0.4% +$1.6K 0.12% 67
2020
Q2
$397K Sell
11,295
-313
-3% -$11K 0.12% 71
2020
Q1
$379K Sell
11,608
-863
-7% -$28.2K 0.14% 59
2019
Q4
$564K Sell
12,471
-55
-0.4% -$2.49K 0.2% 50
2019
Q3
$510K Buy
12,526
+123
+1% +$5.01K 0.19% 48
2019
Q2
$533K Buy
12,403
+45
+0.4% +$1.93K 0.21% 47
2019
Q1
$474K Buy
12,358
+99
+0.8% +$3.8K 0.19% 51
2018
Q4
$433K Buy
+12,259
New +$433K 0.21% 49